IBISWorld’s Pharmaceutical Raw Material Manufacturing market research report offers insightful industry analysis and research into the market at the national level. IBISWorld’s in-depth industry market research is presented in a logical and consistent format. The industry report contains key industry statistics, market size, industry trends, and growth and profit forecasts for a 5-year outlook period.


Industry Threats & Opportunities

  • China accounts for roughly 80% of global Vitamin C output, 70% of citric acid output, and 90% of penicillin output
  • Industry Analysis & Industry Trends

    China is one of the largest producers of pharmaceutical raw materials (PRMs), largely due to its low production cost advantage and large population. China accounts for roughly 90.0% of global vitamin C output, 70.0% of citric acid output and 90.0% of penicillin output.

    Rising health concerns among Chinese people and strong global demand led to rapid industry growth in the past five years. Total revenue for the Pharmaceutical Raw Material Manufacturing industry in China is expected to be $89.78 billion in 2016, up 8.4% from 2015. Over the five years, revenue has been increasing steadily at an average annual rate of 11.7%.

    This industry relies heavily on exports, with over 30% of revenue coming from foreign markets. In 2016, exports are set to reach $27.93 billion, 31.1%...

    Industry Report - Industry Locations Chapter

    East China generates over half of the industry's revenue. Shandong, Jiangsu and Zhejiang are the largest PRM manufacturers in this region, as well as in the country, accounting for 18.0%, 15.2% and 13.9% of total industry revenue, respectively, in 2016. These high levels of industry revenue are due to these provinces having highly developed downstream industries and being close to ports and transport, through which to access foreign markets.

    North China, especially Hebei and Tianjin, is another important PRM production base in China. The majority of market share in this region is held by large companies, such as Shijiazhuang Pharmaceutical Group and North China Pharmaceutical Group.

    Henan, Hubei, Hunan and Guangdong are major production bases in Middle South China. The..

    Additional Insights for the Pharmaceutical Raw Material Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Pharmaceutical Raw Material Manufacturing Industry are

  • Must have a license
  • Establishment of export markets
  • Development of new products
  • IBISWorld analysts also discuss how external factors such as Policies/Legislation and Household Income in the Pharmaceutical Raw Material Manufacturing industry impact industry performance..

    shopping_cartVIEW PURCHASE OPTIONS

    Look under the hood?

    Download a FREE sample report

    Industry Products

    What is the Pharmaceutical Raw Material Manufacturing Industry?

    The Pharmaceutical Raw Material Manufacturing industry in China manufactures active pharmaceutical ingredients for further preparation of finished pharmaceutical products. Typical products in the industry include bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. This industry acts as a bridge between the upstream chemical industry and the downstream medical market.

    Industry Products
    Vitamins and minerals
    Antipyretics and analgesics
    Preparation adjuncts
    Industry Activities
    Antipyretic and analgesic
    Vitamin and mineral
    Hormone and endocrine function regulator
    Antineoplastic drug
    Antiallergic agent
    Enzyme and other biochemical
    Antiseptic and disinfectant
    Preparation adjunct
    Other chemical raw medicine

    Table of Contents

    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Policies/Legislation
  • Household Income
  • Merchandise Trade - Exports (Total)
  • Age Group (60+)
  • Health Expenditure - Government

  • Current Performance
  • Industry profitability
  • International trade
  • Regulatory pressures
  • Chart: Revenue Growth

  • Industry Outlook
  • Profitability
  • Enterprises and employment
  • International trade
  • Table: Pharmaceutical Raw Material Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Pharmaceutical Raw Material Manufacturing Industry Lifecycle vs The Economy

  • Products & Markets
    Supply Chains
    Key Buying Industries
  • Pharmaceutical Manufacturing
  • Pharmacies & Drugstores
  • General Hospitals

  • Key Selling Industries
  • Organic Chemical Material Manufacturing

  • Products & Services
  • Others
  • Vitamins and minerals
  • Antipyretics and analgesics
  • Preparation adjuncts
  • Antibiotics
  • Chart: Pharmaceutical Raw Material Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Direct determinants
  • Indirect determinants

  • Major Markets
  • Preparation manufacturers
  • Exports
  • Hospitals
  • Drug stores
  • Chart: Major Market Segmentation for the Pharmaceutical Raw Material Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Depreciation
  • Environmental care costs
  • Chart: Cost Structure Benchmarking – Sector vs Pharmaceutical Raw Material Manufacturing

  • Basis of Competition
  • Price
  • Development of new products
  • Production efficiencies

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Pharmaceutical Raw Material Manufacturing Industry

  • Industry Globalization
    Major Companies
    Shijiazhuang Pharmaceutical Group Co., Ltd.North China Pharmaceutical CorporationNortheast Pharmaceutical Group Co., Ltd.Zhejiang NHU Co., Ltd.Shandong Xinhua Pharmaceutical Group Co., Ltd.
  • Table: Shijiazhuang Pharmaceutical Group Co., Ltd. - financial performance
  • Table: North China Pharmaceutical Corporation - financial performance
  • Table: Northeast Pharmaceutical Group Co., Ltd. - financial performance
  • Table: Zhejiang NHU Co., Ltd. - financial performance
  • Table: Shandong Xinhua Pharmaceutical Group Co., Ltd. - financial performance

  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Pharmaceutical Raw Material Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Key Statistics
    Table: Industry Data for the Pharmaceutical Raw Material Manufacturing Industry
  • Industry Revenue (2007-2021)
  • Industry Gross Product (2007-2021)
  • Establishments (2007-2021)
  • Businesses (2007-2021)
  • Employment (2007-2021)
  • Exports (2007-2021)
  • Imports (2007-2021)
  • Wages (2007-2021)
  • Total Assets (2007-2021)
  • Pharmaceutical Raw Materials Output (2007-2021)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Jargon & Glossary
    Active Pharmaceutical Ingredient
  • The substance in a pharmaceutical drug that is biologically active.
  • Analgesics
  • Drugs that relieve pain without blocking nerve impulse conduction or markedly altering sensory functions.
  • Antipyretics
  • Drugs that reduce body temperature in situations such as fever.
  • Why buy this report?

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Pharmaceutical Raw Material Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Pharmaceutical Raw Material Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Pharmaceutical Raw Material Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Join IBISWorld today

    Contact Us

    Want to speak to a representative? Call us.